Copyright Reports & Markets. All rights reserved.

Global 3D Bioprinting Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now
  • 1.1 Research Scope
  • 1.2 Market Segmentation
  • 1.3 Research Objectives
  • 1.4 Research Methodology
    • 1.4.1 Research Process
    • 1.4.2 Data Triangulation
    • 1.4.3 Research Approach
    • 1.4.4 Base Year
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on 3D Bioprinting Industry
  • 1.7 COVID-19 Impact: 3D Bioprinting Market Trends

    • 2 Global 3D Bioprinting Quarterly Market Size Analysis

    • 2.1 3D Bioprinting Business Impact Assessment - COVID-19
      • 2.1.1 Global 3D Bioprinting Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
    • 2.2 Global 3D Bioprinting Quarterly Market Size 2020-2021
    • 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
      • 2.3.1 Drivers
      • 2.3.2 Restraints
      • 2.3.3 Opportunities
      • 2.3.4 Challenges

    3 Quarterly Competitive Assessment, 2020

    • 3.1 By Players, Global 3D Bioprinting Quarterly Market Size, 2019 VS 2020
    • 3.2 By Players, 3D Bioprinting Headquarters and Area Served
    • 3.3 Date of Key Players Enter into 3D Bioprinting Market
    • 3.4 Key Players 3D Bioprinting Product Offered
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Impact of Covid-19 on 3D Bioprinting Segments, By Type

    • 4.1 Introduction
      • 1.4.1 Magnetic 3D Bioprinting
      • 1.4.2 Laser-assisted Bioprinting
      • 1.4.3 Inkjet 3D Bioprinting
      • 1.4.4 Microextrusion 3D Bioprinting
    • 4.2 By Type, Global 3D Bioprinting Market Size, 2019-2021

    5 Impact of Covid-19 on 3D Bioprinting Segments, By Application

    • 5.1 Overview
      • 5.5.1 Clinical Applications
      • 5.5.2 Research Applications
      • 5.5.3 Drug and Medical Research
      • 5.5.4 Regenerative Medicine
      • 5.5.5 3D Cell Culture
    • 5.2 By Application, Global 3D Bioprinting Market Size, 2019-2021
      • 5.2.1 By Application, Global 3D Bioprinting Market Size by Application, 2019-2021

    6 Geographic Analysis

    • 6.1 Introduction
    • 6.2 North America
      • 6.2.1 Macroeconomic Indicators of US
      • 6.2.2 US
      • 6.2.3 Canada
    • 6.3 Europe
      • 6.3.1 Macroeconomic Indicators of Europe
      • 6.3.2 Germany
      • 6.3.3 France
      • 6.3.4 UK
      • 6.3.5 Italy
    • 6.4 Asia-Pacific
      • 6.4.1 Macroeconomic Indicators of Asia-Pacific
      • 6.4.2 China
      • 6.4.3 Japan
      • 6.4.4 South Korea
      • 6.4.5 India
      • 6.4.6 ASEAN
    • 6.5 Rest of World
      • 6.5.1 Latin America
      • 6.5.2 Middle East and Africa

    7 Company Profiles

    • 7.1 Organovo Holdings Inc
      • 7.1.1 Organovo Holdings Inc Business Overview
      • 7.1.2 Organovo Holdings Inc 3D Bioprinting Quarterly Revenue, 2020
      • 7.1.3 Organovo Holdings Inc 3D Bioprinting Product Introduction
      • 7.1.4 Organovo Holdings Inc Response to COVID-19 and Related Developments
    • 7.2 EnvisionTEC GmbH
      • 7.2.1 EnvisionTEC GmbH Business Overview
      • 7.2.2 EnvisionTEC GmbH 3D Bioprinting Quarterly Revenue, 2020
      • 7.2.3 EnvisionTEC GmbH 3D Bioprinting Product Introduction
      • 7.2.4 EnvisionTEC GmbH Response to COVID-19 and Related Developments
    • 7.3 Nano3D Biosciences, Inc
      • 7.3.1 Nano3D Biosciences, Inc Business Overview
      • 7.3.2 Nano3D Biosciences, Inc 3D Bioprinting Quarterly Revenue, 2020
      • 7.3.3 Nano3D Biosciences, Inc 3D Bioprinting Product Introduction
      • 7.3.4 Nano3D Biosciences, Inc Response to COVID-19 and Related Developments
    • 7.4 Cyfuse Biomedical K.K
      • 7.4.1 Cyfuse Biomedical K.K Business Overview
      • 7.4.2 Cyfuse Biomedical K.K 3D Bioprinting Quarterly Revenue, 2020
      • 7.4.3 Cyfuse Biomedical K.K 3D Bioprinting Product Introduction
      • 7.4.4 Cyfuse Biomedical K.K Response to COVID-19 and Related Developments
    • 7.5 Advanced Solutions, Inc
      • 7.5.1 Advanced Solutions, Inc Business Overview
      • 7.5.2 Advanced Solutions, Inc 3D Bioprinting Quarterly Revenue, 2020
      • 7.5.3 Advanced Solutions, Inc 3D Bioprinting Product Introduction
      • 7.5.4 Advanced Solutions, Inc Response to COVID-19 and Related Developments
    • 7.6 Aspect Biosystems Ltd
      • 7.6.1 Aspect Biosystems Ltd Business Overview
      • 7.6.2 Aspect Biosystems Ltd 3D Bioprinting Quarterly Revenue, 2020
      • 7.6.3 Aspect Biosystems Ltd 3D Bioprinting Product Introduction
      • 7.6.4 Aspect Biosystems Ltd Response to COVID-19 and Related Developments
    • 7.7 3Dynamic Systems Ltd
      • 7.7.1 3Dynamic Systems Ltd Business Overview
      • 7.7.2 3Dynamic Systems Ltd 3D Bioprinting Quarterly Revenue, 2020
      • 7.7.3 3Dynamic Systems Ltd 3D Bioprinting Product Introduction
      • 7.7.4 3Dynamic Systems Ltd Response to COVID-19 and Related Developments
    • 7.8 regenHU
      • 7.8.1 regenHU Business Overview
      • 7.8.2 regenHU 3D Bioprinting Quarterly Revenue, 2020
      • 7.8.3 regenHU 3D Bioprinting Product Introduction
      • 7.8.4 regenHU Response to COVID-19 and Related Developments
    • 7.9 Cellink
      • 7.9.1 Cellink Business Overview
      • 7.9.2 Cellink 3D Bioprinting Quarterly Revenue, 2020
      • 7.9.3 Cellink 3D Bioprinting Product Introduction
      • 7.9.4 Cellink Response to COVID-19 and Related Developments
    • 7.10 Regenovo Biotechnology Co., Ltd
      • 7.10.1 Regenovo Biotechnology Co., Ltd Business Overview
      • 7.10.2 Regenovo Biotechnology Co., Ltd 3D Bioprinting Quarterly Revenue, 2020
      • 7.10.3 Regenovo Biotechnology Co., Ltd 3D Bioprinting Product Introduction
      • 7.10.4 Regenovo Biotechnology Co., Ltd Response to COVID-19 and Related Developments
    • 7.11 Poietis
      • 7.11.1 Poietis Business Overview
      • 7.11.2 Poietis 3D Bioprinting Quarterly Revenue, 2020
      • 7.11.3 Poietis 3D Bioprinting Product Introduction
      • 7.11.4 Poietis Response to COVID-19 and Related Developments
    • 7.12 GeSiM
      • 7.12.1 GeSiM Business Overview
      • 7.12.2 GeSiM 3D Bioprinting Quarterly Revenue, 2020
      • 7.12.3 GeSiM 3D Bioprinting Product Introduction
      • 7.12.4 GeSiM Response to COVID-19 and Related Developments
    • 7.13 Exone
      • 7.13.1 Exone Business Overview
      • 7.13.2 Exone 3D Bioprinting Quarterly Revenue, 2020
      • 7.13.3 Exone 3D Bioprinting Product Introduction
      • 7.13.4 Exone Response to COVID-19 and Related Developments
    • 7.14 Stratasys
      • 7.14.1 Stratasys Business Overview
      • 7.14.2 Stratasys 3D Bioprinting Quarterly Revenue, 2020
      • 7.14.3 Stratasys 3D Bioprinting Product Introduction
      • 7.14.4 Stratasys Response to COVID-19 and Related Developments
    • 7.15 Advanced BioMatrix
      • 7.15.1 Advanced BioMatrix Business Overview
      • 7.15.2 Advanced BioMatrix 3D Bioprinting Quarterly Revenue, 2020
      • 7.15.3 Advanced BioMatrix 3D Bioprinting Product Introduction
      • 7.15.4 Advanced BioMatrix Response to COVID-19 and Related Developments
    • 7.16 Ricoh Company Ltd
      • 7.16.1 Ricoh Company Ltd Business Overview
      • 7.16.2 Ricoh Company Ltd 3D Bioprinting Quarterly Revenue, 2020
      • 7.16.3 Ricoh Company Ltd 3D Bioprinting Product Introduction
      • 7.16.4 Ricoh Company Ltd Response to COVID-19 and Related Developments

    8 Key Findings

      9 Appendix

      • 9.1 About US

      This report covers market size and forecasts of 3D Bioprinting, including the following market information:
      Global 3D Bioprinting Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global 3D Bioprinting Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global 3D Bioprinting Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global 3D Bioprinting Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)

      Key market players
      Major competitors identified in this market include Organovo Holdings Inc, EnvisionTEC GmbH, Nano3D Biosciences, Inc, Cyfuse Biomedical K.K, Advanced Solutions, Inc, Aspect Biosystems Ltd, 3Dynamic Systems Ltd, regenHU, Cellink, Regenovo Biotechnology Co., Ltd, Poietis, GeSiM, Exone, Stratasys, Advanced BioMatrix, Ricoh Company Ltd, etc.

      Based on the Region:
      Asia-Pacific (China, Japan, South Korea, India and ASEAN)
      North America (US and Canada)
      Europe (Germany, France, UK and Italy)
      Rest of World (Latin America, Middle East & Africa)

      Based on the Type:
      Magnetic 3D Bioprinting
      Laser-assisted Bioprinting
      Inkjet 3D Bioprinting
      Microextrusion 3D Bioprinting

      Based on the Application:
      Clinical Applications
      Research Applications
      Drug and Medical Research
      Regenerative Medicine
      3D Cell Culture

      Buy now